https://www.selleckchem.com/products/mli-2.html
k of death. Our investigators found that hospitalized patients with active cancer were more likely to die from coronavirus disease 2019 (COVID-19) than those with a history of cancer and those without any cancer history. Patients with hematologic cancers were the most likely among patients with cancer to die from COVID-19. Patients who received cancer therapy within 3 months before hospitalization did not have an increased risk of death. Our investigators found that hospitalized patients with active cancer were more likely to die from cor
Mi piace
Commento
Condividi
